Continuing efforts to raise awareness and fight the takeover of the 340B Drug Pricing Program by for-profit pharmacy benefit manager (PBM) contract pharmacies, the Community Oncology Alliance (COA) filed an amicus curiae brief with the United States Court of Appeals for the Third Circuit. The out-of-control growth of 340B contract pharmacy arrangements by mail order and specialty pharmacies owned or affiliated with for-profit PBMs is diverting billions of dollars in discounts meant to help patients in need while fueling the continued takeover of the nation’s health care system by PBMs.

The case is AstraZeneca Pharmaceuticals LP, v. Secretary, U.S. Department of Health and Human Services, et al., case number 22-1676 in the United States District Court for the District of Delaware.